comparemela.com

Latest Breaking News On - Suven pharmaceuticals ltd - Page 9 : comparemela.com

Indian shares set for muted open on risk aversion amid Q4 earnings - Stock market news

BENGALURU (Reuters) - Indian shares were set for a muted start on Friday as investors were cautious after a weak revenue outlook from HCLTech and ahead of the quarterly earnings of the country's top firm by market capitalisation Reliance Industries. | 11:03pm

India generalEileen sorengBharath rajeswaranReliance industriesInfosys ltdHcltech ltd onTejas networksSiemens ltdReliance industries ltdCyient ltdTata consultancy services ltdRail vikas nigam ltdMacrotech developersSuven pharmaceuticals ltdHindustan zinc ltdGujarat metro rail corporation

Indian shares set for muted open on risk aversion amid Q4 earnings

Indian shares were muted on Friday, as investors remained cautious after a weak revenue outlook from HCLTech Ltd and ahead of the quarterly earnings of the country's top firm by market capitalisation, Reliance Industries Ltd .

India generalEileen sorengBharath rajeswaranHindustan zinc ltdGujarat metro rail corporationBerhyanda ltdSuven pharmaceuticals ltdFederal reserveBank ltdThomson reuters trust principlesCompetition commission of indiaInfosys ltdHcltech ltdReliance industriesCyient ltdReliance industries ltd

CCI clears Berhyanda s stake acquisition in Suven Pharma

Berhyanda Ltd is a wholly-owned subsidiary of Berhyanda Midco Ltd, which is an affiliate of Advent International Corporation.

Competition commission of indiaBerhyanda midco ltdSuven pharmaceuticals ltdAdvent international corporationBerhyanda ltdCompetition commissionSuven pharmaceuticalsAdvent internationalSubstantial acquisitionPharmaceuticals ltdSuven pharma

Private Equity Major Advent To Buy Significant Stake In Suven Pharma

Private equity major Advent International will buy a "significant" stake in Suven Pharmaceuticals from its promoter Jasti family.

Andhra pradeshVenkateswarlu jastiCohance lifesciencesSuven pharmaceuticalsEquity holdings private ltdSuven pharmaceuticals ltdAdvent internationalPrivate equity major advent to buySignificant stake in suven pharmaManaging director venkateswarlu jastiJasti propertyVideo of thePrivate equity major advent international

Advent to buy 50% in Suven Pharma for ₹6,313 crore

Advent International agreed to acquire 50.1% of Suven Pharmaceuticals Ltd from the Jasti family, promoters of the company, for ₹6,313 crore

Suven pharmaceuticals ltdAdvent internationalSuven pharmaceuticalsJasti family

vimarsana © 2020. All Rights Reserved.